Cognitive Effects of Atomoxetine in Humans: Genetic Moderators

Conditions

Addiction

What is the purpose of this trial?

The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects of atomoxetine.



Participation Guidelines

Age:
21 Years - 50 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
December 2011
Last Updated:
December 12, 2013
Study HIC#:
1103008235

Clinicaltrials.gov ID: NCT01498549